Novel carbocyclic nucleosides containing a cyclobutyl ring. Guanosine and adenosine analogues

Nucleosides and Nucleotides

Volumn 17, Issue 7, 1998, Pages 1237-1253

  Borges, José E R ^a   Fernández, Franco ^a   García, Xerardo ^a   Hergueta, Antonio R ^a   López, Carmen ^a   Andrei, Graciela ^b   Snoeck, Robert ^b   Witvrounw, Myriam ^b   Balzarini, Jan ^b   De Clercq, Erik ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 [3 (5 AMINO 7 CHLORO 3H 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 3 YL) 2,2 DIMETHYLCYCLOBUTYL]ETHANOL; 2 [3 (5,6 DIAMINO 3H 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 3 YL) 2,2 DIMETHYLCYCLOBUTYL]ETHANOL; 2 [3 (6 AMINO 9H PURIN 9 YL) 2,2 DIMETHYLCYCLOBUTYL]ETHANOL; 2 [3 (7 AMINO 3H 1,2,3 TRIAZOLO[4,5 D] PYRIMIDIN 3 YL) 2,2 DIMETHYLCYCLOBUTYL]ETHANOL; 3 DEAZAARISTEROMYCIN; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 5 AMINO 6,7 DIHYDRO 3 [3 (2 HYDROXYETHYL) 2,2 DIMETHYLCYCLOBUTYL] 3H 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 7 ONE; 6,7 DIHYDRO 3 [3 (2 HYDROXYETHYL) 2,2 DIMETHYLCYCLOBUTYL] 3H 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 7 ONE; 9 (2,3 DIHYDROXYPROPYL)ADENINE; ACICLOVIR; ADENOSINE DERIVATIVE; ANTIVIRUS AGENT; CARBOCYCLIC NUCLEOSIDE; CYCLOBUTANE DERIVATIVE; GANCICLOVIR; GUANOSINE DERIVATIVE; NUCLEOSIDE DERIVATIVE; RIBAVIRIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA VIRUS; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LYMPHOID CELL; NONHUMAN; RNA VIRUS; T LYMPHOCYTE; VACCINIA VIRUS;

DNA VIRUSES; HERPES; RNA VIRUSES; SIMPLEXVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0003865019     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808004236     Document Type: Article

References (18)

1. De Clercq, E. J. Med. Chem., 1995, 38, 2491.
2. De Clercq, E. Rev. Med. Virol., 1995, 5, 149.
3. Seki, J.; Shimada, N.; Takashashi, K.; Takita, T.; Takeuchi, T.; Hoshino H. Antimicrob. Agents Chemother., 1989, 33, 773.
4. Norbeck, D. W.; Kern, E.; Hayashi, S.; Rosenbrook, W.; Sham, H.; Herrin, T.; Plattner, J. J.; Erickson, J.; Clement, J.; Swanson, R.; Shipkowitz, N.; Hardy, D.; Marsh, K.; Arnett, G.; Shannon, W.; Broder, S.; Mitsuya, H. J. Med. Chem., 1990, 33, 1281.
5. Hayashi, S.; Norbeck, D. W.; Rosenbrook, W.; Fine, R. L.; Matsukura, M.; Plattner, J. J.; Broder, S.; Mitsuya, H. Antimicrob. Agents Chemother., 1990, 34, 287.
6. Bisacchi, G. S.; Braitman, A.; Cianci, C. W.; Clark, J. M.; Field, A. K.; Hagen, M. E.; Hockstein, R. D.; Malley, M. F.; Mitt, T.; Slursarchyk, W. A.; Sundeen, J. E.; Terry, B. J.; Tuomari, A. V.; Weaver, E.; Young, M. G.; Zahler, R. J. Med. Chem., 1991, 34, 1415.
7. Nishiyama, Y.; Yamamoto, Y.; Yamada, Y.; Daikoku, T.; Ichicawa, T.; Takahashi, K. J. Antibiotics, 1989, 52, 1854.
8. Braitman, A.; Swerdel, M. R.; Olsen, S. J.; Tuomari, A. V.; Lynch, J. S.; Blue, B.; Michalik, T.; Field, A. K.; Bonner, D. P.; Clark, J. M. Antimicrob. Agents Chemother., 1991, 35, 1464.
9. Borges, J. E. R.; Fernández, F.; García, X.; Hergueta, A. R.; López, C. Org. Prep. Proc. Int., 1997, 29, 303.
10. Shealy, Y. F.; Clayton, J. D. J. Am. Chem. Soc., 1966, 88, 3885. Ibid., 1969, 91, 3075.
11. Shealy, Y. F.; Clayton, J. D. J. Am. Chem. Soc., 1966, 88, 3885. Ibid., 1969, 91, 3075.
12. Vince, R.; Hua, M. J. Med. Chem., 1990, 33, 17.
13. Shealy, Y. F.; Clayton, J. D. J. Pharm. Sci., 1973, 62, 1432.
14. Daluge, S.; Vince, R. J. Org. Chem., 1978, 43, 2311.
15. Patil, S. D.; Koga, M.; Schneller, S. W. J. Med. Chem., 1992, 35, 2191.
16. De Clercq, E. in "In vitro and ex vivo test systems to rationalize drug design and delivery", D. Crommelin, P. Couvreur, D. Duchêne (Eds.), Editions de Santé, Paris, France, 1994, pp 108-125.
17. De Clercq, E.; Descamps, J.; Verhelst, G.; Walter, R. T.; Jones, A. S.; Torrence, P. F.; Shugar, D. J. Infect. Dis. 1980, 141, 563.
18. De Clercq, E.; Holý, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal; P. C.; Nature 1986, 323, 464